Clinical Trial

Comparing Hypothermic Temperatures During Hemiarch Surgery

Study acronym: TITAN:COMMENCE
Recruiting
View on ClinicalTrials.gov →
Summary
Hypothermic circulatory arrest is an important surgical technique, allowing complex aortic surgeries to be performed safely. Hypothermic circulatory arrest provides protection to cerebral and visceral organs, but may result in longer cardiopulmonary bypass times during surgery, increased risks of bleeding, inflammation, and neuronal injury. To manage these consequences, a trend towards warmer core body temperatures during circulatory arrest has emerged. This trial will randomize patients to either mild (32°C) or moderate (26°C) hypothermia during aortic hemiarch surgery to determine if mild hypothermia reduces the length of cardiopulmonary bypass time and other key measures of morbidity and mortality.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2016-08-08; most recent amendment 2025-09-18.
Status change: Active, Not Recruiting → Recruiting 2021-03-09
Status change: Recruiting → Active, Not Recruiting 2020-04-03
Status change: Not Yet Recruiting → Recruiting 2018-04-10
Trial Details
NCT Number NCT02860364
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions Thoracic Aortic Disease
Enrollment 282 participants
Start Date 2018-02-20
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-24